BILOGICAL DEFENSE VACCINE STOCKS

File: 970101_sep96_decls40_0001.txt
Page: 0001
Total Pages: 2

Subject: BILOGICAL DEFENSE VACCINE STOCKS                                

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003201

Folder Title: BIOLOGICAL DEFENSE VACCINE STOCKS                                                               

Document Number:       1001

Folder Seq  #:         44



                                          UNCLASSIFIED



                                  DEPARTMENT OF THE ARMY
                                  OFFIC@OF THE SURGEON GENERAL
                                       5109 LEESBURG PIKE
                                   FALLS CHURCH, VA 22041-3258
                 REPLY TO
                 A@ENTION OF
           DASG-RDZ  (50k)                                            2 MAY 1991


           MEMORANDUM FOR CHIEF OF STAFF, ARMY

           SUBJECT: Biological Defense Vaccine Stocks       INFORMATION
           MEMORANDUM (U)


           1. @ The contingency stocks in Southwest Asia (SWA) of
           biological defense vaccines against anthrax and botulism and
           botulinum antitoxin may have been lost due to equipment (generator,
           refrigeration) failure. A medical logistics team departed 1 May to
           recover all biological defense products and the associated
           storage/chain of custody records and will return them to CONUS.
           The status of some of these products will remain in question until
           these records are reviewed and appropriate tests are conducted.
           The Army will follow Food and Drug Administration (FDA) regulations
           to determine the proper disposition of products in question. This
           investigation will take several months to determine the efficacy
           and safety of the vaccines for human use.

           2.  @ The depletion of the vaccine stocks in CONUS coupled with
           the potential loss in SWA results in an urgent need to address
           methods of reestablishing the vaccine stocks. The



                                    Lred to start production of anthrax vaccine
           and are critical to meet the DOD requirements.

           3. +4                                        have refused to provide
           inuemnir---
                   icalion ror products tor wnicn tnere is no defined period
on, nor a guarantee that
           recipients can be matched with product lots. Legal opinions imply
           that, unless there is a stated urgent and compelling need to
           replenish the stocks, the Army should refrain from providing
           indemnification.

           4.  @ The Joint Staff is currently staffing an action for the
           Secretary of Defense which cites an urgent and compelling need. In
           parallel, the ODCSOPS is drafting a memo for the Army Acquisition
           office stressing the operational need for a fully configured
           stockpile.                  DECLASSIFIED
                                       ON: 12 DEC 96
                                       BY: SEC ARMY (DAMH) UNDER SEC 3.4 EO 12958
           CLASSIFIED BY: MULTIPLE SOURCES
           DECLASSIFY ON: OADR
                                       UNCLASSIFIED
                                       ;g r. P. D r. T
                                        '%JLUI k L-F

Document 2 f:/Week-36/BX003201/BIOLOGICAL DEFENSE VACCINE STOCKS/bilogical defense vaccine stocks:12249609313341
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = BIOLOGICAL DEFENSE VACCINE STOCKS
Folder Seq # = 44
Subject = BILOGICAL DEFENSE VACCINE STOCKS
Document Seq # = 1001
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 24-DEC-1996